Cytori Therapeutics (CYTX) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Total product revenues: 1.47M
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Total product revenues: 1.47M
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q3 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Greenlane Holdings Inc. (GNLN) reported Q2 result
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
